ALNYLAM PHARMACEUTICALS, INC. (40) | Stock Agreements (3)
- Description of Capital Stock (Filed With SEC on February 13, 2020)
- Stock Purchase Agreement dated as of April 8, 2019 by and between the Registrant and Regeneron Pharmaceuticals, Inc (Filed With SEC on August 6, 2019)
- Amended and Restated 2004 Employee Stock Purchase Plan, as amended (Filed With SEC on May 2, 2019)
